Android app on Google Play

Morning Movers 04/24: (ALIM) (ALGN) (CLS) Higher; (BIG) (NFLX) (HSTM) (CRDN) Lower

April 24, 2012 10:53 AM EDT Send to a Friend
Alimera Sciences, Inc., (Nasdaq: ALIM) 24.9% HIGHER; today announced the Austrian Agency for Health and Food Safety (Osterreichische Agentur fur Gesundheit und Ernahrungssicherheit, AGES) has granted marketing authorization to ILUVIENĀ® for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. Click here to see the full release.

Big Lots, Inc. (NYSE: BIG) 20.2% LOWER; now expect Q1 U.S. comparable store sales to be slightly negative compared to our prior guidance issued on March 2, 2012, which estimated a comparable store sales increase of 2% to 4%. U.S. comparable store sales were on plan through the first six weeks of the quarter; however, sales compared to plan began to slow in late March and trends have further softened as we moved through the month of April. From a merchandising perspective, furniture, hardlines, and seasonal, particularly lawn and garden, have been our best performing businesses; whereas, consumables and play n' wear, particularly electronics, are currently below expectations for the quarter. In terms of our recently acquired Canadian operations, based on results quarter-to-date, we anticipate retail sales for the first quarter of fiscal 2012 will be slightly above our guidance which estimated sales in the range of $25 to $30 million.

Align Technology, Inc. (NASDAQ: ALGN) 14.7% HIGHER; reported Q1 EPS of $0.27, $0.06 better than the analyst estimate of $0.21. Revenue for the quarter came in at $135.1 million versus the consensus estimate of $128.05 million. Align Technology, Inc. sees Q2 2012 EPS of $0.26-$0.28, versus the consensus of $0.24.

Netflix, Inc. (NASDAQ: NFLX) 13% LOWER; reported Q1 EPS of ($0.08), $0.19 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $870 million versus the consensus estimate of $868.07 million. Sees Q2 revs of $873-$895M versus the consensus of $897.35M. Sees Q2 loss of $0.10 - to EPS of $0.14, versus the consensus of a loss of $0.17.

HealthStream, Inc. (NASDAQ: HSTM) 13% LOWER; reported Q1 EPS of $0.05, $0.01 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $23.7 million versus the consensus estimate of $22.75 million.

Ceradyne, Inc. (NASDAQ: CRDN) 13% LOWER; reported Q1 EPS of $0.16, $0.21 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $106.3 million versus the consensus estimate of $120.08 million. Sees FY2012 EPS of $1.40-$1.65, versus prior guidance of $2.30-$2.65 and the consensus of $2.40. Sees FY2012 revenue of $540-$565 million, versus prior guidance of $590-$625 million and the consensus of $595.80 million.

Sanmina-SCI Corp (NASDAQ: SANM) 12.7% LOWER; reported Q2 EPS of $0.27, in-line with the analyst estimate of $0.27. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.51 billion. Sanmina-sci Corp sees Q3 2012 EPS of $0.26-$0.32, versus the consensus of $0.37.

Celestica, Inc. (NYSE: CLS) 11.2% HIGHER; reported Q1 EPS of $0.25, $0.04 better than the analyst estimate of $0.21. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.67 billion. Sees Q2 2012 EPS of $0.20-$0.26, versus the consensus of $0.25. Sees Q2 2012 revenue of $1.65-$1.75 billion, versus the consensus of $1.76 billion.

Symantec (Nasdaq: SYMC) 9.5% LOWER; reports preliminary Q4 sales of $1.68 billion and EPS of 38 cents. The company had previously guided Q4 sales to $1.72-$1.73 billion and EPS to 41-42 cents. The Street is currently looking for Q4 sales of $1.73 billion and EPS of 42 cents.




You May Also Be Interested In


Related Categories

Special Reports

Related Entities

Morning Movers

Add Your Comment